Tandem Diabetes Care | TNDM - Operating Profit


Tandem Diabetes Care reported $8.29M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Accuray USD 4.71M 6.86M Dec/2024
Align Technology USD 224.71M 40.06M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Orthofix International USD -84.62M 65.72M Dec/2024
Roche Holding CHF 9.56B 3.8B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025